You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Iothalamate sodium i-125 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for iothalamate sodium i-125 and what is the scope of patent protection?

Iothalamate sodium i-125 is the generic ingredient in one branded drug marketed by Isotex and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Recent Clinical Trials for iothalamate sodium i-125

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 2
National Institutes of Health (NIH)Phase 1
National Heart, Lung, and Blood Institute (NHLBI)Phase 1

See all iothalamate sodium i-125 clinical trials

Pharmacology for iothalamate sodium i-125

US Patents and Regulatory Information for iothalamate sodium i-125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Isotex GLOFIL-125 iothalamate sodium i-125 INJECTABLE;INJECTION 017279-001 Approved Prior to Jan 1, 1982 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.